Dingdang Health Buys Back 0.45 Million Shares, Expands Treasury Stock to 1.94 Million

Bulletin Express09-03 19:03

Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 449,000 ordinary shares on 3 September 2026 via on-market transactions on the Hong Kong Stock Exchange.

The shares were repurchased at prices ranging from HKD 0.87 to HKD 0.895, with a volume-weighted average of HKD 0.888 per share. The total consideration amounted to HKD 0.40 million.

Key share capital movements: • Opening balance on 2 September 2026: 1.24 billion issued shares (excluding 1.49 million treasury shares). • Shares repurchased on 3 September 2026: 0.45 million, equal to 0.0362 % of the pre-transaction issued share base. • Closing balance post-transaction: 1.24 billion issued shares (excluding 1.94 million treasury shares); total issued shares unchanged at 1.24 billion, as the repurchased stock is held in treasury rather than cancelled.

Repurchase mandate status: • Authorised limit (approved 23 June 2026): up to 124.32 million shares. • Cumulative repurchases under the mandate, including the latest transaction: 4.80 million shares, representing 0.39 % of the issued share count at mandate date. • In line with HKEX rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share sales until 3 October 2026.

The company confirmed that all repurchases were executed in compliance with Hong Kong listing regulations and relevant legal requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155322456?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-03 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155322456","market":"us","top_or_hot":-1,"title":"Dingdang Health Buys Back 0.45 Million Shares, Expands Treasury Stock to 1.94 Million","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 449,000 ordinary shares on 3 September 2026 via on-market transactions on the Hong Kong Stock Exchange.</p>\n<p>The shares were repurchased at prices ranging from HKD 0.87 to HKD 0.895, with a volume-weighted average of HKD 0.888 per share. The total consideration amounted to HKD 0.40 million.</p>\n<p>Key share capital movements:\n• Opening balance on 2 September 2026: 1.24 billion issued shares (excluding 1.49 million treasury shares).  \n• Shares repurchased on 3 September 2026: 0.45 million, equal to 0.0362 % of the pre-transaction issued share base.  \n• Closing balance post-transaction: 1.24 billion issued shares (excluding 1.94 million treasury shares); total issued shares unchanged at 1.24 billion, as the repurchased stock is held in treasury rather than cancelled.</p>\n<p>Repurchase mandate status:\n• Authorised limit (approved 23 June 2026): up to 124.32 million shares.  \n• Cumulative repurchases under the mandate, including the latest transaction: 4.80 million shares, representing 0.39 % of the issued share count at mandate date.  \n• In line with HKEX rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share sales until 3 October 2026.</p>\n<p>The company confirmed that all repurchases were executed in compliance with Hong Kong listing regulations and relevant legal requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Buys Back 0.45 Million Shares, Expands Treasury Stock to 1.94 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Buys Back 0.45 Million Shares, Expands Treasury Stock to 1.94 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-03 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 449,000 ordinary shares on 3 September 2026 via on-market transactions on the Hong Kong Stock Exchange.</p>\n<p>The shares were repurchased at prices ranging from HKD 0.87 to HKD 0.895, with a volume-weighted average of HKD 0.888 per share. The total consideration amounted to HKD 0.40 million.</p>\n<p>Key share capital movements:\n• Opening balance on 2 September 2026: 1.24 billion issued shares (excluding 1.49 million treasury shares).  \n• Shares repurchased on 3 September 2026: 0.45 million, equal to 0.0362 % of the pre-transaction issued share base.  \n• Closing balance post-transaction: 1.24 billion issued shares (excluding 1.94 million treasury shares); total issued shares unchanged at 1.24 billion, as the repurchased stock is held in treasury rather than cancelled.</p>\n<p>Repurchase mandate status:\n• Authorised limit (approved 23 June 2026): up to 124.32 million shares.  \n• Cumulative repurchases under the mandate, including the latest transaction: 4.80 million shares, representing 0.39 % of the issued share count at mandate date.  \n• In line with HKEX rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share sales until 3 October 2026.</p>\n<p>The company confirmed that all repurchases were executed in compliance with Hong Kong listing regulations and relevant legal requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1155322456","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155322456","pubTimestamp":1788433417,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 449,000 ordinary shares on 3 September 2026 via on-market transactions on the Hong Kong Stock Exchange. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康回购45万股，库存股扩大至194万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 449,000 ordinary shares on 3 September 2026 via on-market transactions on the Hong Kong Stock Exchange.\nThe shares were repurchased at prices ranging from HKD 0.87 to HKD 0.895, with a volume-weighted average of HKD 0.888 per share. The total consideration amounted to HKD 0.40 million.\nKey share capital movements:\n• Opening balance on 2 September 2026: 1.24 billion issued shares (excluding 1.49 million treasury shares).  \n• Shares repurchased on 3 September 2026: 0.45 million, equal to 0.0362 % of the pre-transaction issued share base.  \n• Closing balance post-transaction: 1.24 billion issued shares (excluding 1.94 million treasury shares); total issued shares unchanged at 1.24 billion, as the repurchased stock is held in treasury rather than cancelled.\nRepurchase mandate status:\n• Authorised limit (approved 23 June 2026): up to 124.32 million shares.  \n• Cumulative repurchases under the mandate, including the latest transaction: 4.80 million shares, representing 0.39 % of the issued share count at mandate date.  \n• In line with HKEX rules, Dingdang Health is subject to a 30-day moratorium on new share issues or treasury share sales until 3 October 2026.\nThe company confirmed that all repurchases were executed in compliance with Hong Kong listing regulations and relevant legal requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155322456","isCrawlerRequest":true}